Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CTNM
3076
Contineum Therapeutics
CTNM
$494M
| $574K | ﹤0.01% |
43,958
-15,549
| -26% | -$209K |
2024 Q2
7 quarters
|
|
3077
BioLife Solutions
BLFS
$1.82B
| $574K | ﹤0.01% |
30,065
-34,029
| -53% | -$752K |
2018 Q3
30 quarters
|
|
|
BCAX
3078
Bicara Therapeutics
BCAX
$1.17B
| $573K | ﹤0.01% |
28,823
-74,418
| -72% | -$1.28M |
2024 Q3
6 quarters
|
|
3079
International Seaways
INSW
$5.74B
| $573K | ﹤0.01% |
7,862
-54,875
| -87% | -$3.51M |
2016 Q4
37 quarters
|
|
3080
Universal Technical Institute
UTI
$1.07B
| $573K | ﹤0.01% |
15,870
-254,839
| -94% | -$8.04M |
2020 Q2
23 quarters
|
|
3081
Citizens Community Bancorp
CZWI
$206M
| $572K | ﹤0.01% |
28,887
-8,190
| -22% | -$151K |
2024 Q3
6 quarters
|
|
3082
LegalZoom.com
LZ
$959M
| $571K | ﹤0.01% |
100,789
-160,188
| -61% | -$1.22M |
2021 Q2
19 quarters
|
|
3083
KVH Industries
KVHI
$127M
| $571K | ﹤0.01% |
63,703
+216
| +0.3% | +$1.51K |
2017 Q1
36 quarters
|
|
|
DMRA
3084
Damora Therapeutics
DMRA
$1.27B
| $571K | ﹤0.01% |
+22,034
| New | +$566K |
2026 Q1
0 quarters
|
|
|
DX
3085
Dynex Capital
DX
$2.73B
| $570K | ﹤0.01% |
44,691
-248,946
| -85% | -$3.42M |
2016 Q2
39 quarters
|
|
|
AIOT
3086
PowerFleet Inc
AIOT
$377M
| $570K | ﹤0.01% |
185,095
-144,679
| -44% | -$606K |
2024 Q2
7 quarters
|
|
|
LADR
3087
Ladder Capital
LADR
$1.09B
| $569K | ﹤0.01% |
58,242
-225,318
| -79% | -$2.37M |
2014 Q1
48 quarters
|
|
3088
Heritage Financial
HFWA
$1.15B
| $568K | ﹤0.01% |
21,856
-42,698
| -66% | -$1.11M |
2016 Q2
39 quarters
|
|
3089
Regenxbio
RGNX
$490M
| $565K | ﹤0.01% |
67,427
-96,994
| -59% | -$1.02M |
2016 Q3
38 quarters
|
|
3090
El Pollo Loco
LOCO
$433M
| $565K | ﹤0.01% |
40,754
-38,416
| -49% | -$440K |
2014 Q4
45 quarters
|
|
3091
Malibu Boats
MBUU
$453M
| $564K | ﹤0.01% |
21,745
-24,668
| -53% | -$736K |
2016 Q1
40 quarters
|
|
3092
Southern California Bancorp
BCAL
$700M
| $563K | ﹤0.01% |
31,788
-18,510
| -37% | -$339K |
2024 Q2
7 quarters
|
|
3093
Amplify Energy
AMPY
$181M
| $563K | ﹤0.01% |
90,240
+44,942
| +99% | +$244K |
2025 Q4
1 quarter
|
|
3094
Virtus Investment Partners
VRTS
$886M
| $563K | ﹤0.01% |
4,190
-7,063
| -63% | -$1.04M |
2016 Q1
40 quarters
|
|
3095
Alto Neuroscience
ANRO
$973M
| $563K | ﹤0.01% |
25,036
-5,356
| -18% | -$99.3K |
2024 Q1
8 quarters
|
|
3096
PROG Holdings
PRG
$1.23B
| $563K | ﹤0.01% |
19,610
-78,601
| -80% | -$2.54M |
2022 Q1
16 quarters
|
|
3097
Clarivate
CLVT
$947M
| $561K | ﹤0.01% |
221,750
-82,357
| -27% | -$211K |
2019 Q3
26 quarters
|
|
3098
John Wiley & Sons Class A
WLY
$2.41B
| $561K | ﹤0.01% |
14,717
-55,345
| -79% | -$1.79M |
2013 Q2
51 quarters
|
|
3099
Digi International
DGII
$2.87B
| $561K | ﹤0.01% |
11,632
-53,379
| -82% | -$2.5M |
2022 Q3
14 quarters
|
|
3100
Costamare
CMRE
$1.87B
| $560K | ﹤0.01% |
33,110
-115,643
| -78% | -$1.92M |
2013 Q4
49 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.